Bicara Therapeutics Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
BCAX on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 Main Street, Cambridge, MA

Insiders trading volume in the past year

Bicara Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kiran Mazumdar-Shaw Director, 10%+ Owner $83.2M Jun 9, 2025
Biocon Ltd 10%+ Owner $73.2M Sep 16, 2024
Ra Capital Management, L.P. Director, 10%+ Owner $35.1M Jun 9, 2025
Tpg Gp A, Llc Former 10% Owner $26M Sep 16, 2024
James E. Flynn Possible Members of 10% Group, 10%+ Owner $23.8M Sep 17, 2024
Fmr Llc Other* $14.8M Sep 16, 2024
FIL Ltd Other* $13.4M Sep 16, 2024
Claire Mazumdar Chief Executive Officer, Director $5.85M -$1.7M -22.5% Nov 24, 2025
Ryan Cohlhepp President and COO, Director $3.49M -$1.36M -28.1% Nov 21, 2025
Ivan Hyep Chief Financial Officer $2.7M -$1.01M -27.3% Nov 21, 2025
David Raben Chief Medical Officer $669K -$611K -47.7% Nov 24, 2025
Nils Lonberg Director $397K Jun 9, 2025
Kate Haviland Director $98.5K Jun 9, 2025
Lara Meisner Chief Legal Officer $0 -$1.87M -100% Sep 29, 2025
Scott M. Robertson Director Jun 9, 2025
Jake Simson Director Jun 9, 2025
Michael Powell Director Jun 9, 2025
Christopher Bowden Director Jun 9, 2025
Carolyn Ng Director Sep 12, 2024

Recent Insider Transactions by Companies or Individuals for Bicara Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.